Edition:
United States

People: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

8.69USD
23 Sep 2016
Change (% chg)

$0.25 (+2.96%)
Prev Close
$8.44
Open
$8.71
Day's High
$9.19
Day's Low
$8.54
Volume
4,856,974
Avg. Vol
1,440,392
52-wk High
$10.95
52-wk Low
$5.57

Fisherman, Jason 

Dr. Jason S. Fisherman, M.D., is an Independent Director of Achillion Pharmaceuticals, Inc., since March 2000. Since 2007, Dr. Fisherman has been a Managing Director of Synthesis Capital (formerly known as Advent Healthcare Ventures), a life science venture capital firm he co-founded in 2007. From 2002 to 2007, Dr. Fisherman was a Managing Director of Advent International, a global private equity firm which he joined in 1994. Prior to Advent, Dr. Fisherman served for four years as Senior Director of Medical Research for Enzon Pharmaceuticals and previously managed the clinical development of a number of oncology drugs at the National Cancer Institute. Dr. Fisherman is currently a director of several private biopharmaceutical companies and previously served on the Board of Directors of Aegerion Pharmaceuticals, a public biopharmaceutical company, from December 2005 until April 2011. Dr. Fisherman received his B.A. from Yale University, his M.D. from the University of Pennsylvania and his M.B.A. from the Wharton School of the University of Pennsylvania. Dr. Fisherman’s qualifications include his scientific experience, notably in clinical development and strategic product development. In addition to drug research and clinical development expertise, Dr. Fisherman brings a wealth of venture capital management experience in such areas as financing, business development and alliance formation.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --